Psilocybin therapy for bipolar ii depression
Treatments studied
Part of Mental health clinical trials.
This study tests whether a psychedelic drug called psilocybin (the active ingredient in 'magic' mushrooms), combined with therapy, can help relieve depression in people with bipolar II disorder who haven't gotten better with other treatments. You'll receive the drug in a supervised setting and attend follow-up visits to see how it affects your mood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 19 and 65 years old.
- You must have bipolar II disorder and be currently in a major depressive episode.
- You must be able to speak and understand English well enough to follow the study and give consent.
- Your current depression medications must have been at a stable dose for at least 2 weeks before the study starts.
- You must be willing to use effective birth control (or abstain from sex) during the study if you're able to have children.
- You cannot have a history of psychosis, seizures, or have used psychedelics in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if two doses of psilocybin, given under medical supervision, are safe and acceptable for people with Bipolar II disorder who have mild to moderate depression and certain suicidal thoughts. The goal is to see if it may help improve mood and reduce suicidal thinking.
This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.
This trial tests whether a medicine called psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help treat depression. You would have a few sessions with a therapist and receive the medicine in a safe setting, which might improve your mood.
This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.
This trial tests whether a treatment called psilocybin (a hallucinogen that can help with depression) combined with group therapy can improve symptoms of depression. It requires participants to have significant depression symptoms and a support person to drive them home after each session.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
Hear when a new Bipolar II Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.